从受孕至2岁期间改善营养暴露与成年期心血管代谢疾病风险:一项模型研究
该研究对危地马拉4个村庄1962年1月1日至1977年2月28日出生、曾参与蛋白质-能量营养补充(Atole)整群随机试验的2392人队列进行随访,2015年2月26日至2017年4月29日可随访1661人,实际研究684名女性和455名男性,评估37-54岁时心血管代谢疾病风险。结果显示从受孕至2岁暴露于Atole与肥胖风险升高、舒张压升高、血脂升高相关,与糖尿病风险降低相关,性别间存在分层异质性。作者认为早期蛋白质-能量营养补充对预防成年心血管代谢疾病能力不一。
要点
- 从受孕至2岁暴露于Atole与肥胖风险升高相关(OR 1.94,95%CI 1.11-3.40)。
- 从受孕至2岁暴露于Atole与糖尿病风险降低相关(OR 0.46,95%CI 0.21-0.97)。
- 非HDL胆固醇和餐后血糖存在性别分层异质性,交互作用P值分别为0.09和0.04。
核心结论
- 从受孕至2岁改善蛋白质-能量营养可降低37-54岁时的糖尿病风险,但该补充也增加肥胖及若干肥胖相关状况的风险。
- 作者认为,在儿童期发育迟缓率高和成年期超重/肥胖率高的背景下,早期蛋白质-能量营养补充预防成年心血管代谢疾病发病的能力不一。
研究设计与样本
- 对危地马拉4个村庄1962年1月1日至1977年2月28日出生、曾参与蛋白质-能量营养补充(Atole)整群随机试验的2392人队列进行随访。
- 2015年2月26日至2017年4月29日可随访1661人,研究纳入684名女性和455名男性。
- 采用人体测量、空腹及餐后血糖、空腹血脂和血压评估37-54岁时心血管代谢疾病风险,使用广义线性模型和逻辑回归模型估计效应。
主要发现
- 从受孕至2岁暴露于Atole与体质指数增加1.29 kg/m2(95%CI 0.08至2.50)、体脂增加1.73%(95%CI 0.20至3.26)、肥胖风险升高(OR 1.94,95%CI 1.11至3.40)相关。
- 从受孕至2岁暴露于Atole与舒张压升高1.59 mm Hg(95%CI -0.74至3.92)、总胆固醇升高10.10 mg/dL(95%CI 0.80至19.40)、非HDL胆固醇升高10.41 mg/dL(95%CI 1.51至19.31)相关。
- 从受孕至2岁暴露于Atole与餐后血糖降低5.84 mg/dL(95%CI -12.51至0.83)及糖尿病风险降低(OR 0.46,95%CI 0.21至0.97)相关。
- 合并模型中性分层异质性:非HDL胆固醇女性4.34 mg/dL(95%CI -6.86至15.55)vs 男性19.84 mg/dL(95%CI 5.86至33.82);餐后血糖女性-0.19 mg/dL(95%CI -8.63至8.24)vs 男性-13.10 mg/dL(95%CI -23.64至-2.56);性别与暴露交互作用P值分别为0.09和0.04。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low-income and middle-income countries with populations that are chronically undernourished in early life are undergoing a nutrition transition and are experiencing an epidemic of cardiometabolic disease. These dual burdens are thought to be causally related; therefore, the extent to which improvements in early-life nutrition can offset adult-onset disease is important. The aim of this study was to examine whether improvement of protein-energy nutrition from conception to age 2 years can attenuate the risk of cardiometabolic disease. METHODS: We followed up a cohort of 2392 individuals born between Jan 1, 1962, and Feb 28, 1977, in four villages in Guatemala who had participated in a cluster-randomised protein-energy nutritional supplementation (Atole) trial. Of 1661 participants available for follow-up from Feb 26, 2015, to April 29, 2017, we studied 684 women and 455 men. We assessed cardiometabolic disease risk at ages 37-54 years using anthropometry, fasting and post-challenge glucose, fasting lipid concentrations, and blood pressure. We used generalised linear and logistic regression modelling to estimate the effect of Atole from conception to age 2 years (the first 1000 days) on cardiometabolic disease risk. FINDINGS: Exposure to Atole from conception to age 2 years was associated with increased fatness (body-mass index [1·29 kg/m2, 95% CI 0·08 to 2·50], body fat [1·73%, 0·20 to 3·26], and obesity [odds ratio 1·94, 1·11 to 3·40]), diastolic blood pressure (1·59 mm Hg, -0·74 to 3·92), and blood lipids (total cholesterol [10·10 mg/dL, 0·80 to 19·40] and non-HDL cholesterol [10·41 mg/dL, 1·51 to 19·31]), reduced post-challenge glucose (-5·84 mg/dL, -12·51 to 0·83), and reduced odds of diabetes (odds ratio 0·46, 0·21 to 0·97). We found stratum heterogeneity by sex in pooled models for non-HDL cholesterol (4·34 mg/dL, 95% CI -6·86 to 15·55 for women vs 19·84 mg/dL, 5·86 to 33·82 for men) and post-challenge glucose (-0·19 mg/dL, -8·63 to 8·24 for women vs -13·10 mg/dL, -23·64 to -2·56 for men). p values for interaction of sex and exposure to Atole from conception to age 2 years were 0·09 and 0·04, respectively. INTERPRETATION: Improved protein-energy nutrition from conception to the 2nd birthday reduced the odds of diabetes at ages 37-54 years; however, this protein-energy supplementation also increased the risk of obesity and several obesity-related conditions. Our findings suggest a mixed ability of protein-energy nutritional supplementation in early life to prevent adult cardiometabolic disease incidence in the context of high childhood stunting and high adult overweight and obesity. FUNDING: National Institutes of Health.
引用
- Ford ND, Behrman JR, Hoddinott JF, et al. Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: a modelling study. Lancet Glob Health. 2018. PMID: 30012268. doi:10.1016/S2214-109X(18)30231-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。